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Abstract
Aim We conducted a systematic review aggregate and network meta-analysis of psychological interventions for people
with type 1 diabetes to assess their effectiveness in improving glycaemic levels.
Methods We searched the following databases from 1 January 2003 to 1 July 2018: MEDLINE, CINAHL, PsycINFO,
Embase, Cochrane Controlled Trials, Web of Science, clinicaltrials.gov, Dissertation Abstract International. We included
randomized controlled trials (RCT) of psychological interventions for children and adults with type 1 diabetes reported
in any language. We extracted data on publications, participant characteristics at baseline, intervention and control
group, and data for the primary outcome, change in glycaemic control [HbA1c (mmol/mol/%)]. Study authors were
contacted for missing data. The review was registered with international prospective register of systematic reviews
registration (PROSPERO) CRD42016033619.
Results Twenty-four adult RCTs and 23 of children with type 1 diabetes were included in the systematic review. In
aggregate meta-analysis there was no overall effect of psychological intervention compared with control on HbA1c
[adults, nine RCTs, n = 1102, pooled mean difference 0.12, 95% confidence intervals (CI) 0.27 to 0.03, I2 = 29.0%,
P = 0.19; children, 20 RCTs, n = 2567, 0.09, 95% CI 0.22 to 0.04, I2=54.0% P=0.002]. Network meta-analysis
suggested that probability and rank-ordering of effectiveness is highest for attention control groups (b = 0.47, 95% CI
0.80 to 0.12) followed by cognitive behavioural therapy (CBT) (0.26, 95% CI 0.45 to 0.06) compared with
usual care for adults.
Conclusions Overall psychological interventions for children and adults with type 1 diabetes do not improve glycaemic
control. For adults, CBT-based interventions have the potential to be effective.
Diabet. Med. 00, 1–12 (2020)
Introduction
Successful self-management of type 1 diabetes involves the
acquisition, implementation and maintenance of complex
skills including frequent blood glucose monitoring, carbohy-
drate counting and calculations of insulin dose to achieve
optimal glycaemic control and avoid diabetes-related
complications. Although emerging technologies are increas-
ingly available to assist people with type 1 diabetes, self-
management remains highly complex and psychologically
demanding. It is associated with high levels of psychological
comorbidity, such as anxiety [1], depression [2] and eating
disorders [3], and these problems are more prevalent in
adults and children with diabetes and suboptimal glycaemic
control [4,5].
International guidelines [6–8], suggest that children and
adults with type 1 diabetes should receive screening and
psychological support in order to treat common psychological
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problems and relieve the daily stress of diabetes self-manage-
ment. Access to a range of mental health specialists is recom-
mended to support children, their families and thediabetes team.
Evidence suggests that for children, families and adultswith type
1 diabetes, psychological support is important at the time of
diagnosis to enable adjustment to the condition [9,10]. How-
ever,what typeofpsychological intervention shouldbedelivered
in terms of the psychological techniques or underlying psycho-
logical theory is open to debate. Interventions for adults and
children are likely to be different, as for children these will most
often involve the family group, and there may be specific
underlying problems that need to be addressed, such as
hyperglycaemia, hypoglycaemia unawareness [11], fear of
hypoglycaemia [12] and fear of complications [13].
Our previous systematic review and meta-analysis [14] of
psychological interventions for children/adolescents and
adults with type 1 diabetes demonstrated that psychological
interventions were effective for improving glycaemic control
for children, but not adults. As this was published more than
15 years ago we wanted to update it because: (1) different
psychological treatments are being used and tested; (2) the
statistical methods for synthesizing data across trials have
progressed (such as using network meta-analytic techniques
which can simultaneously analyse multiple treatments across
studies); and (3) most studies include glycaemic control to
assess diabetes self-management, whereas psychological out-
comes vary across studies. Therefore, we considered the time
was right to update our previous review and conduct a
systematic review, aggregate and network-meta-analysis of
RCTs to determine the effectiveness of psychological inter-
ventions in improving glycaemic control for children/adoles-
cents and adults with type 1 diabetes.
Methods
This systematic review and meta-analysis followed the same
protocol as for our earlier published review [14]. The main
outcome was change in HbA1c (mmol/mol/%). We made a
number of minor changes to the protocol such as additional
details of the intervention in accordance with frameworks to
improve intervention description and potential for replica-
tion [15]. Network meta-analysis was added to maximize the
information gained from multiple treatment arms and
control groups and comparisons, our updated protocol was
published [16], and registered with the international prospec-
tive register of systematic reviews registration (PROSPERO)
CRD42016033619. We employed the Cochrane risk of bias
tool to assess study quality [17]. We followed the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement [18].
Eligibility criteria
Inclusion criteria were RCTs of a psychological intervention
for children or adolescents or adults with type 1 diabetes. In
brief, psychological interventions were defined as utilizing the
therapeutic alliance between the individual(s) and therapist,
facilitated by psychologists, psychotherapists or therapists,
facilitated or supervised by the same, where the intervention
was basedonapsychologicalmodel andaimed to improve self-
management. Studies were reported in any language. We
categorized psychological interventions as follows: (1) sup-
portive or counselling therapy, including motivational inter-
viewing; (2) cognitive behavioural therapy (CBT), including
techniques commonly used in CBT such as relaxation, cogni-
tive re-structuring, goal-setting, problem-solving; (3) psycho-
dynamic or interpersonal psychotherapy; and (4) family
systems therapy. Newer therapies that may not fall into these
categories, or interventions that did not explicitly describe the
intervention or techniques underwent consensus discussion by
an academic liaison psychiatrist, health psychologist and
therapist trained in motivational interviewing (KI, RU, KW
respectively). If agreement still could not be reached, theywere
excluded. We defined comparators as usual care, waiting list,
and attention control (matched the number of sessions in the
intervention arm) and diabetes education.
The main outcome was change in glycaemic control using
HbA1c (mmol/mol or %) between baseline and follow-up,
closest to 12 months.
Information sources
We searched the following online databases from 1 January
2003 to 1 July 2018: MEDLINE (OVID), CINAHL,
PsycINFO, Embase (OVID), Cochrane Controlled Trials
Database, Web of Science, https://clinicaltrials.gov and
Dissertation Abstracts International. We searched conference
proceedings for a 5-year period (2012 to 2018): Diabetes UK,
What’s new?
• A previous systematic review and meta-analysis of
randomized controlled trials (RCT) of psychological
interventions to improve glycaemic control demon-
strated an effect for children with type 1 diabetes but
not adults, with a reduction in HbA1c of 5 mmol/mol
(0.5%).
• The current review synthesized data from nine adult
(n = 1102) and 20 child RCTs (n = 2567) in an
aggregate meta-analysis; there was no improvement/
reduction in HbA1c for children or adults.
• Network meta-analysis for adults demonstrated that
cognitive behavioural therapy (CBT) and attention
control were associated with statistically and clinically
significant HbA1c reduction.
• Psychological interventions are not indicated for
improving glycaemic control for people with type 1
diabetes. For adults, CBT-based interventions have the
potential to be effective.
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American Diabetes Association, European Association for
the Study of Diabetes and International Diabetes Federation.
In addition to our earlier systematic review protocol we
checked Web of Science, clinicaltrials.gov and Dissertation
Abstracts International as these have become leading repos-
itories over the last 15 years. We also checked reference lists
of included studies and other reviews, leading authors,
experts and investigators of ongoing RCTs were contacted.
Search
The Cochrane collaboration’s optimum search strategy was
used and ‘diabetes mellitus’, ‘psychological therapies’ and
‘mood disorders’, and ‘clinical trials’ were used to search
MEDLINE and adjusted for other databases (see Table S1).
Study selection
Title and abstract screening of articles arising from the search
was conducted by two independent reviewers (RU and KW)
to determine whether articles met the inclusion criteria. Inter-
rater reliability was conducted to determine agreement for
inclusion of studies. Studies were included if there was a
disagreement. We excluded quasi RCT, N-of-1 and any study
design other than RCTs.
Data collection and data items
Full-text review was conducted by both reviewers who
independently extracted study data; non-English studies were
translated and data was extracted by a native speaker. Any
disagreements regarding final inclusion were discussed with a
third reviewer (KI) until consensus was reached. For studies
with multiple publications, we included the one with data at
baseline and follow-up nearest to 12 months. For aggregate
meta-analysis, we included data from the most intensive
psychological intervention if there were multiple treatments
and included data from all intervention and control treatment
arms in the networkmeta-analysis.We requested missing data
from study authors. Data was extracted on publication status
such as country of origin and year. Participants characteristics
included: age, gender, ethnicity, glycaemic control at baseline,
duration of type 1 diabetes, and type of diabetes treatment.
When studies included people with both type 1 and type 2
diabetes, only data on type 1 diabetes was extracted if findings
had been stratified. Intervention characteristics were coded as
type, duration, number of sessions, mode of delivery (individ-
ual, group, family), therapist characteristics (profession),
manualized treatment, duration of follow up and follow-up
HbA1c. The intensity of the psychological intervention was
determined by the number and duration of sessions (h) and the
duration of the intervention (months). Data were extracted on
the psychological theory underpinning the intervention,
fidelity to the intervention and training and competency of
the therapist.
Statistical analysis and synthesis of results
To determine study quality, the Cochrane risk of bias (RoB)
tool [17] was used independently by RU and KW to
determine, high, low or unclear RoB both within and
between studies. Disagreement was resolved by a third
researcher. Subgroup meta-analysis was conducted according
to RoB rating, and we used meta-regression to compare the
effect sizes between RoB groups.
In aggregate meta-analysis (combining data from one
treatment and control arm across studies) the standardized
mean difference (SMD), Cohen’s d, was calculated to
determine change in HbA1c (mmol/mol or %) between
baseline and 12-month follow-up or closest to that data
point. Random effect meta-analysis was used to pool SMDs.
We calculated absolute HbA1c values from the pooled SD and
multiplied it by the overall SMD. The following diagnostic
analyses were conducted: the effect of removing individual
studies; Egger’s publication bias; and funnel plots [19], trim
and fill [20], to determine potential for missing studies. We
conducted meta-regression if there were five or more studies
with data that could be pooled [21]. Meta-analyses were
conducted using STATA 14 (StataCorp, College Station, TX,
USA).
We combined the data from our previous meta-analysis
with that of the current one to determine cohort effects after
removing any duplicate studies.
The network meta-analysis involved analysis of direct and
indirect effects of all of the treatment and control arms
included in each study on the mean change in HbA1c [22].
Indirect effects compared categories of intervention (psycho-
logical interventions, alternative treatments) or control
groups (usual care, attention control, waiting list, diabetes
education) within and across studies. Network plots were
constructed to show direct comparisons, we included con-
trasts in which there were at least two study sites contribut-
ing data. Random effects meta-analysis allowing for
heterogeneity and inconsistency between the studies was
conducted [23]. We compared direct and indirect effects of
the contrast I-J and Wald tests to determine inconsistency
[24]. Hedges’ g formula was used to determine unbiased
SMDs corrected for degrees of freedom for different cate-
gories of intervention with usual care as the control.
Potential ranks for each category were estimated using
cumulative probability plots and surface under the cumula-
tive ranking (SUCRA), the higher SUCRA (closest to one) the
greater probability the intervention is effective.
Results
Study selection
We identified 31 609 study citations (Fig. 1). Once duplicates
were removed, 23 080 citations underwent title and abstract
screening; 547 full text articles were selected for further
ª 2020 The Authors.
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extraction. There was 94.5% agreement for identifying
abstracts for full retrieval (Cohen’s kappa 0.95). Twenty-
four adult and 23 child/adolescent type 1 diabetes RCTs met
inclusion criteria for the systematic review. Reasons for the
exclusion of the other studies are given in Fig. 1.
Study characteristics
The studies included in the systematic review are listed and
synthesized in Tables S2 and S3.
There was a broad range of clinical settings and/or criteria
and for adult studies included in the systematic review, these
included diabetes duration (n = 9) [S1–S9], age (n = 21) [S1–
S5,S7–S22], suboptimal HbA1c (n = 10) [S1,S2,S4–S6,S8,S9,
S16,S22,S23], depressive symptoms (n = 4) [S7,S12,S16,S24]
and emotional well-being (n = 1) [S20]. There were no adult
studies delivering psychodynamic, interpersonal therapy or
family therapy, 12 studies delivered counselling [S4,S5,S9–
S11,S15,S17,S18,S21–S24] and 12 CBT [S1–S3,S6–S8,S12–
S14,S16,S19,S20]. In the control group, there were 11, 6 and
7 studies, administering usual care [S2,S4,S10,S14–S18,S20,
S21,S24], attention control [S5–S8,S12,S23] or waiting list
control [S1,S3,S9,S11,S13,S19,S22], respectively. Most ther-
apists were diabetes specialists (n = 12) [S1,S2,S4,S8–S10,
S13,S14,S17,S21–S23], psychology professionals (n = 9) [S3,
S5–S7,S11,S12,S16,S19,S20] and ‘other’ (n = 3), defined as
non-diabetes health professionals (n = 2) [S15,S24] and
peers (n = 1) [S18]. Most interventions were delivered face-
to-face (n = 21) [S1–S9,S11–S17,S19,S20,S22–S24], via tele-
phone (n = 2) [S10,S18], face-to-face and telephone (n = 1)
[S21], and mostly to groups (n = 12) [S1,S4,S6,S8,S9,S11–
S13,S16,S17,S20,S22] or one-to-one (n = 12) [S2,S3,S5,S7,
S10,S14,S15,S18,S19,S21,S23,S24]. The mean number of
therapy sessions offered was 7.68 (SD 2.67); the mean
duration of each session was 1.58 h (SD 0.60); and mean
duration of therapy was 5.3 months (SD 5.02). For adult
studies, nine referred to an intervention manual [S1,S2,S5–
S8,S11,S14,S16] of which four provided a link to the manual
[S2,S7,S14,S16], and nine studies provided a link to the study
protocol [S2,S3,S6,S7,S11,S14,S16,S17,S21].
For child/adolescent studies included in the systematic
review, clinical settings and/or criteria included diabetes
duration (n = 20) [S25–S44], age (n = 22) [S25–S34,S36–
S43,S45–S47] and suboptimal HbA1c (n = 9) [S26–S28,S30,
S35,S38,S40,S42,S44]. There were no child/adolescent stud-
ies delivering a psychodynamic or interpersonal therapy, nine
delivered counselling [S25,S26,S32,S33,S39–S42,S45], eight
CBT [S29,S31,S34,S36,S37,S43,S46,S47] and six family
systems therapy [S27,S28,S30,S35,S38,S44]. In the control
group, there were 10, 11 and 2 studies administering usual
care [S26,S28,S32,S34,S37,S38,S41,S44,S45,S47], attention
control [S25,S27,S29–S31,S33,S36,S39,S40,S42,S43] or
waiting list control [S35,S46], respectively. Therapists were
diabetes specialists (n = 5) [S25,S26,S32,S42,S45], psychol-
ogy professionals (n = 10) [S27–S30,S35,S37,S43,S44,S46,
S47] and ‘other’ [defined as research assistants, non-diabetes
health professionals (n = 8)] [S31,S33,S34,S36,S38–S41].
Most interventions were delivered face-to-face (n = 18)
[S25-S32,S34,S37,S40–S47], via telephone (n = 3) [S33,
S35,S36], face-to-face and telephone (n = 2) [S38,S39], and
to groups (n = 6) [S26,S29,S42,S45–S47] or one-to-one
(n = 5) [S25,S32,S36,S41,S43] or family (n = 12) [S27,S28,
S30,S31,S33-S35,S37–S40,S44]. The mean number of ther-
apy sessions offered was 7.84 (SD 7.30); the mean duration of
each session was 1.24 h (SD 0.84); and the mean duration of
therapy was 9.02 months (SD 7.30). For child/adolescent
studies, five referred to an intervention manual [S26,S39,S42,
S44,S47] of which three provided a link to the manual [S26,
S39,S47]; eight studies provided a link to the study protocol
[S26–S29,S32,S33,S35,S36].
Synthesis of results
There were nine adult studies with HbA1c data to be pooled,
giving a total sample of n = 1102. In the random effects meta-
analysis there was a non-statistically significant reduction in
HbA1c for psychological intervention compared with the
control group [SMD 0.12, 95% confidence intervals (CI)
0.27 to 0.03), equivalent to 2 mmol/mol (0.2%) reduction in
HbA1c (Fig. 2). Heterogeneity was low and non-significant (I
2
= 29.0%,P = 0.19).When Snoek et al. [S6] orHermanns et al.
[S12] was removed as part of diagnostic analyses to determine
the influence of individual studies, there was a significant
decrease in HbA1c in favour of psychological intervention
(SMD 0.15, 95% CI 0.30 to 0.0002; SMD 0.17, 95%
CI0.30 to0.04, respectively), both equivalent to reduction
in HbA1c of 2 mmol/mol (0.2%). There was no evidence of
publication bias (Egger’s test,P = 0.87).No additional studies
were considered missing using trim and fill method. For adult
studies, themajority of studies included a 12-month follow-up
(n = 6) and follow-up ranged between 5 and 48 months.
To examine whether there was a cohort effect, we pooled
the HbA1c data from 11 adult RCTs included in an earlier
meta-analysis (from inception to January 2004) with the
current review (January 2003 to July 2018), totalling 20
RCTs (n = 1618). We derived a similar effect size to the
current review (SMD 0.12, 95% CI 0.26 to 0.02), with
no significant difference in effect sizes between reviews
(b = 0.004, 95% CI 0.36 to 0.35, P = 0.98).
For children/adolescents, 20 studies had HbA1c data to be
pooled giving a total sample ofn = 2567. In the randomeffects
meta-analysis, there was a non-statistically significant reduc-
tion in HbA1c for psychological intervention compared with
the control group (SMD 0.09, 95% CI 0.22 to 0.04),
equivalent to a 1mmol/mol (0.1%) reduction inHbA1c (Fig. 3).
Heterogeneity was moderate and significant (I2 = 54.0%,
P = 0.002). Therewas no evidence of publication bias (Egger’s
test, P = 0.30), and no missing studies were detected. For
child/adolescent studies, the majority included a 12-month
follow-up (n = 12) and follow-up ranged from3 to 18months.
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Records aer duplicates removed
(n = 23 080)
Records screened
(n =23 080)
Records excluded
(n =22 533)
Full-text arcles assessed for 
eligibility
(n = 547)
Full-text arcles excluded*
(n = 499)
Studies included in 
qualitave synthesis
(T1D adults: n = 24
T1D adolescents/children: 
n = 23)**
Studies included in 
quantave synthesis (meta-
analysis)
(T1D adults: n = 9
T1D adolescents/children:
n = 20)***
FIGURE 1 Qualitative and quantitative flowchart for all type 1 diabetes studies. *Reasons for exclusion: protocol (n = 41), conference abstracts
(n = 37), outcome of interest reported in separate paper (n = 22), intervention not defined as psychological (n = 215), glycaemic control not
measured (n = 47), not RCT (n = 25), unable to access study (n = 10), no diabetes (n = 8), type 2 diabetes (n = 95). **Fourteen type 1 diabetes
adult studies and two type 1 diabetes child/adolescent studies were papers that included populations with type 1 and type 2 diabetes where separate
analysis per diabetes type could not be obtained. The remaining single type 1 diabetes adult study and two type 1 diabetes child/adolescent studies
that were not included in meta-analysis, did not provide enough information for meta-analysis. ***Three type 1 diabetes adult studies had
populations with type 1 and type 2 diabetes where separate analysis per diabetes type was obtained.
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To examine whether there was a cohort effect, we pooled
the HbA1c data from 10 child/adolescent RCTs included in
an earlier meta-analysis (from inception to January 2004)
with the current review (January 2003 to July 2018), giving a
total of 28 RCTs (n = 3018). We derived a similar effect size
to the current review (SMD 0.11, 95% CI 0.29 to 0.06),
with no significant difference in effect sizes between reviews
(b = 0.27, 95% CI 1.05 to 0.51, P = 0.48).
Risk of bias across studies
For adults, four studies were rated ‘unclear’ RoB and five
studies were rated ‘low’ RoB (Fig. S1). The domains which
were most ‘unclear’ risk were ‘random sequence generation’
and ‘blinding of participants and personnel’ (Fig. S2).
For children/adolescents, four studies were rated ‘low’ RoB
and 16 ‘unclear’ RoB (Fig. S3). Between studies, ‘blinding of
participants and personnel’ was rated most ‘unclear’
(Fig. S4).
Additional analyses
For the meta-regression for adults, there was no association
between number of sessions (b = 0.03, 95% CI 0.09 to
0.02, P = 0.20), or session duration (b = 0.01, 95% CI
0.36 to 0.36, P = 0.94), or duration of treatment
(b = 0.004, 95% CI 0.03 to 0.02, P = 0.63) and HbA1c.
It was not possible to conduct sub-analyses for intervention-
ist category. It was not possible to perform meta-regression
for studies with an inclusion criterion of suboptimal gly-
caemic control as this included most of the studies in the
meta-analysis. See Tables S4 and S5, respectively for case
definitions and whether HbA1c was a primary or secondary
outcome of included studies.
For children and adolescents, sub-analyses for interven-
tionist category demonstrated that there was a borderline
statistically significant reduction in HbA1c in favour of
psychological interventions delivered by psychology profes-
sionals (n = 8, SMD 0.26, 95% CI 0.53 to 0.00,
P = 0.05) equivalent to a reduction of 3 mmol/mol HbA1c
(0.3%), and a non-significant reduction for ‘other’ interven-
tionists (n = 7, SMD 0.02, 95% CI 0.12 to 0.08,
P = 0.70), but a non-significant increase for diabetes spe-
cialists (n = 5, SMD 0.03, 95% CI 0.34 to 0.40, P = 0.87).
This difference was non-significant in meta-regression
(P = 0.31). Heterogeneity was moderate and significant for
psychology professionals (I2 = 60.8%, P = 0.01), low and
non-significant for ‘other’ (I2 = 0.0%, P = 0.92), and
FIGURE 2 Forest plot for a random-effects meta-analysis of standardized mean difference in HbA1c comparing psychological intervention vs. control
group for adults with type 1 diabetes. References can be found in the online Supporting Information (Doc. S1).
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moderate and significant for diabetes specialist (I2 = 73.7%,
P = 0.004) studies. There was no association between
number (b = 0.014, 95% CI 0.05 to 0.02, P = 0.40) or
duration (b = 0.04, 95% CI 0.21 to 0.13, P = 0.60) of
sessions, or duration of treatment (b = 0.0008, 95% CI
0.005 to 0.007, P = 0.79) and HbA1c. Meta-regression
revealed a non-significant difference in HbA1c between
control group categories (b = 0.09, 95% CI 0.53 to
0.34, P = 0.63). Sub-analyses for interventionist category
demonstrated a non-significant reduction in HbA1c for
counselling (n = 9, SMD 0.00, 95% CI 0.18 to 0.17,
P = 0.99) and CBT (n = 7, SMD 0.24, 95% CI 0.58 to
0.09, P = 0.15). A meta-regression found no significant
difference between these group effect sizes (P = 0.46). A
meta-regression comparing studies that had an inclusion
criterion of suboptimal glycaemic control (5 of 20) vs. those
that did not demonstrated no difference between the two
groups effect sizes (b = 0.25, 95% CI 0.11 to 0.60,
P = 0.16). See Tables S6 and S7, respectively for case
definitions and whether HbA1c was a primary or secondary
outcome of included studies.
Network meta-analysis synthesis
Network meta-analysis was conducted for nine adult studies,
which included two categories of psychological intervention
and three control conditions. One study, Ismail et al. [S2],
had two treatment arms (CBT, counselling), therefore 19
treatment and control arms were included, sample size
n = 1219 (Table 1). CBT (N = 7) and counselling (N = 3)
were the psychological intervention categories, usual care
(N = 4), waiting list (N = 3) and attention control (N = 2)
were the comparators (Table 1). With five conditions, 10
contrasts were possible and six were investigated (Fig. S5).
FIGURE 3 Forest plot for a random-effects meta-analysis of standardized mean difference in HbA1c comparing psychological intervention vs. control
group for children and adolescents with type 1 diabetes. References can be found in the online Supporting Information (Doc. S1).
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Estimated direct and indirect effects between interventions
did not differ significantly (Table S8).
Table 2 shows the results of consistency network meta-
analysis comparing treatments against usual care. Only CBT
and attention control show significant reduction of HbA1c
outcome compared with usual care. Effect sizes were small
(CBT) or medium (attention control). The non-significant v2
test for inconsistency (v2 (3) = 0.30,P = 0.96, I2 = 0) supports
model consistency. Table S9 summarizes pairwise compar-
isons of treatment effect. The rankogram (Fig. S6) and SUCRA
(Table 3) indicate that attention control has highest probabil-
ity of being the best treatment, followed by CBT.
Network meta-analysis was conducted for 19 child/ado-
lescent studies; therefore 19 treatment and 19 control arms
were included (sample size n = 2589; Table 4). CBT (N = 7)
and counselling (N = 9) were the main categories of
psychological intervention, usual care (N = 9) and attention
control (N = 8) main controls. With six conditions, 15
contrasts were possible and seven were investigated (Fig. S7).
Estimated direct and indirect effects between interventions
did not differ significantly (Table S10). Table 5 shows results
of consistency network meta-analysis comparing treatments
against usual care. The non-significant v2 test for inconsis-
tency (v2 (2) = 0.90, P = 0.64, I2 = 0) supports model
consistency. No treatment showed a significant reduction
of treatment outcome compared with usual care. Pairwise
comparisons are shown in Table S11.
The rankogram (Fig. S8) and SUCRA (Table 6) indicate
that CBT and attention control had the highest probability of
being the best treatment.
Discussion
We conducted a systematic review and meta-analysis of
psychological interventions for children/adolescents and
adults with type 1 diabetes. We identified 48 studies, 29 of
which had HbA1c data that could be included in a meta-
analysis. The main findings indicate that, in contrast to our
earlier study [14], psychological interventions were not more
effective than control conditions in improving glycaemic
control for children/adolescents with type 1 diabetes. In
accordance with the earlier review, glycaemic control was not
improved in adults. The negative findings did not change
when data from the earlier review were pooled. Therefore, the
findings from the current review are likely to be more reliable
considering that trial reporting standards have improved and
so has the quality of the included studies [25]. For both
children/adolescent and adult studies, there was no evidence
of a dose–response relationship in terms of intensity of
psychological treatment, although most interventions
involved fewer than eight sessions. For children and adoles-
cents, there was a trend indicating that interventions delivered
by psychology professionals were associated with a small
improvement/reduction in HbA1c of ~ 3mmol/mol (0.3%),
although not significantly different from interventions deliv-
ered by diabetes specialists or other interventionists.
We were able to conduct network meta-analysis and for
adults, taking all comparisons into account, attention control
and CBT interventions were associated with significant
improvement/reduction in HbA1c compared with usual care;
attention control having the largest effect size and probabil-
ity of being the best treatment. One explanation for this is
that attention control groups involved interventions specific
to diabetes self-management, including blood glucose aware-
ness training [26] and diabetes education [27]. Therefore, it
is possible that in addition to attention control interventions,
CBT for adults with type 1 diabetes has potential to support
and improve diabetes self-management [28] and HbA1c.
Table 1 Number of studies and arms included in the network meta-
analyses for adults with type 1 diabetes
Arm N (%)t Arm N
CBT 7 (36.8) T 352
Counselling 3 (15.8) T 299
Usual care 4 (21.1) C 301
Attention control 2 (10.5) C 103
Waiting list 3 (15.8) C 164
Total 19 (100) 1219
CBT, cognitive behavioural therapy; T, defined as treatment
arm in original study; C, defined as control group in original
study.
Table 2 Summary of treatment effects compared with treatment as usual assuming common heterogeneity estimate for all treatment design
comparisons for adults with type 1 diabetes
Treatment b 95% CI SE z P-value
Usual care 0
CBT 0.256 (0.452 to 0.059) 0.1 2.55 0.011
Counselling 0.122 (0.316 to 0.071) 0.099 1.24 0.22
Attention control 0.456 (0.797 to 0.115) 0.174 2.62 0.009
Waiting list 0.017 (0.281 to 0.247) 0.135 0.13 0.90
b, standardized mean difference using treatment as usual as control group. The formulas for Hedges’ g in White and Thomas [24] are used.
CBT, cognitive behavioural therapy.
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Strengths of this study are that it was protocolized,
registered with PROSPERO and conducted according to
PRISMA guidelines [18]. We attempted to identify published
and grey literature, conducted hand-searching and our search
was not language restricted. Authors were contacted for
missing data and we used two meta-analytic approaches to
synthesize data.
Limitations are that we were unable to determine from
included studies whether participants had prior access to
psychological therapy that may have influenced response to
treatment, nor was it possible to determine whether thera-
pists were competent to deliver the psychological treatment.
However, the majority of adult studies were either manual-
ized or provided a link to the study protocol, whereas few
child/adolescent studies did. It could be argued that some of
the psychological therapies such as motivational interviewing
which is therapist-led and was included under the counselling
umbrella, are not as person-centred as traditional counselling
therapy. However, keeping MI within this category allowed
us to merge data with our previous review [14] and there
were too few studies overall to conduct meta-regression.
Despite having no language restriction, we identified most
studies from North America and Western Europe. This
review focused on glycaemic control and did not detect other
potential benefits of psychological treatments, such as
emotional well-being and diabetes self-management beha-
viour. These outcomes were considered in a separate report
[29] although there was insufficient data that could be pooled
in meta-analysis. Also, this report focused on the nearest
follow-up to 12 months, and we acknowledge that although
most studies included this time point there was variation and
for some follow-up was measured from baseline and for
others post treatment. Furthermore, we also accept that
reviewing studies with longer-term interventions and follow-
up may be required.
Explanations as to why this systematic review and meta-
analysis demonstrated no effect of psychological treatments
on glycaemic control for adults may be a consequence of the
limited number of studies identified and the fact that the
main outcome may not have been glycaemic control. Or for
example, for some studies reduction in HbA1c may not have
been the main aim of psychological treatment if participants
had hypoglycaemia unawareness [30]. The reasons for the
Table 3 Mean rank and surface under the cumulative curve for adults
with type 1 diabetes derived from ranking probabilities
Mean rank SUCRA Order of treatment
Usual care 4.4 0.1 5
CBT 2.1 0.7 3
Counselling 3.2 0.5 2
Attention control 1.1 1 1
Waiting list 4.3 0.2 4
SUCRA, surface under the cumulative curve; CBT, cognitive
behavioural therapy.
Table 4 Number of studies and arms included in the network meta-
analyses for children and adolescents with type 1 diabetes
Treatment N (%) Arm N
CBT 7 (18.4) T 266
Counselling 9 (23.7) T 780
Usual care 9 (23.7) C 970
Attention control 8 (21.1) C 258
Family therapy 3 (7.9) T 283
Waiting list 2 (5.3) C 32
Total 38 (100) 2589
CBT, cognitive behavioural therapy; T, defined as treatment
arm in original study; C, defined as control group in original
study.
Table 5 Summary of treatment effects compared with treatment as usual assuming common heterogeneity estimate for all treatment design
comparisons for children and adolescents with type 1 diabetes
Treatment b 95% CI SE z P-value
Usual care 0
CBT 0.332 (1.204 to 0.541) 0.445 0.75 0.46
Counselling 0.164 (0.655 to 0.983) 0.418 0.39 0.69
Attention control 0.267 (1.239 to 0.706) 0.496 0.54 0.59
Family therapy 0.106 (1.298 to 1.085) 0.608 0.17 0.86
Waiting list 0.179 (1.41 to 1.767) 0.81 0.22 0.83
b, standardized mean difference using treatment as usual as control group. The formulas for Hedges’ g in White and Thomas [24] are used.
CBT, cognitive behavioural therapy.
Table 6 Mean rank and surface under the cumulative curve for
children and adolescents with type 1 diabetes derived from ranking
probabilities
Treatment Mean rank SUCRA Order of treatment
Usual care 3.8 0.4 4
CBT 2.4 0.7 1
Counselling 4.4 0.3 6
Attention control 2.7 0.7 1
Family therapy 3.4 0.5 3
Waiting list 4.2 0.4 4
SUCRA, surface under the cumulative curve; CBT, cognitive
behavioural therapy.
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decreased effectiveness for psychological interventions for
children and adolescents with type 1 diabetes are not clear
and require international debate among diabetes and mental
health professionals working in this field. For adults with
type 1 diabetes, psychological interventions are predomi-
nantly limited to CBT and suggest that researchers may find
it difficult to obtain funding for psychotherapies that are not
on some government lists of approved therapies [31]. For
children/adolescents, there were a few large studies in which
participants received a low dose of intervention and this
appears too little to reverse the suboptimal glycaemic control
which has existed for more than 10 years in the UK [32], and
other developed countries [33]. Treatment fidelity was not
reported in any of the included studies and yet this is likely to
influence the ‘dose’ of psychological treatment that is
received [34].
Despite clinical guidelines suggesting the time of diagnosis
an important time to offer psychological support [6–8], only
one study specifically targeted children/adolescents at this time
[35]. Future studiesmaywant to clearly define the target group
and underlying issue being addressed, focus on therapies that
potentially offer benefit such as CBT for adults, look to
combine psychological and self-management support, and
look to develop targeted novel psychotherapies.
Therefore, although guidelines for the treatment of children
and adults with type 1 diabetes recommend access to psycho-
logical services, there is no evidence to suggest that psycho-
logical treatments overall improve glycaemic control.
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